Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives $63.83 Average PT from Analysts
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven brokerages that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 1 year […]
More Stories
TransMedics Group (NASDAQ:TMDX) Raised to “Strong-Buy” at Baird R W
Baird R W upgraded shares of TransMedics Group (NASDAQ:TMDX – Free Report) to a strong-buy rating in a research note...
The Progressive Co. (NYSE:PGR) Insider Sells $775,320.00 in Stock
The Progressive Co. (NYSE:PGR – Get Free Report) insider Steven Broz sold 2,982 shares of the stock in a transaction...
Christopher K. Cox Sells 10,000 Shares of Meta Platforms, Inc. (NASDAQ:META) Stock
Meta Platforms, Inc. (NASDAQ:META – Get Free Report) insider Christopher K. Cox sold 10,000 shares of Meta Platforms stock in...
Robert J. Scaringe Sells 83,333 Shares of Rivian Automotive, Inc. (NASDAQ:RIVN) Stock
Rivian Automotive, Inc. (NASDAQ:RIVN – Get Free Report) CEO Robert J. Scaringe sold 83,333 shares of the firm’s stock in...
Granite Ridge Resources (NYSE:GRNT) versus Sable Offshore (NYSE:SOC) Financial Analysis
Granite Ridge Resources (NYSE:GRNT – Get Free Report) and Sable Offshore (NYSE:SOC – Get Free Report) are both small-cap oils/energy...
Ouster (NYSE:OUST) Given “Neutral” Rating at Cantor Fitzgerald
Cantor Fitzgerald reissued their neutral rating on shares of Ouster (NYSE:OUST – Free Report) in a research note published on...